Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
在CAR-T细胞疗法时代，早期治疗失败仍然是复发或难治性大B细胞淋巴瘤患者预后不良的一个因素。
期刊:Journal of Clinical and Experimental Hematopathology
影响因子:1.4
doi:10.3960/jslrt.24009
Yagi, Yu; Kanemasa, Yusuke; Sasaki, Yuki; Goto, Sotaro; Yamamura, Yasuhiko; Masuda, Yusuke; Fujita, Kumiko; Ishimine, Kento; Hayashi, Yudai; Mino, Mano; Ohigashi, An; Morita, Yuka; Tamura, Taichi; Nakamura, Shohei; Okuya, Toshihiro; Matsuda, Shinichiro; Shimizuguchi, Takuya; Shingai, Naoki; Toya, Takashi; Shimizu, Hiroaki; Najima, Yuho; Kobayashi, Takeshi; Haraguchi, Kyoko; Doki, Noriko; Okuyama, Yoshiki; Shimoyama, Tatsu
